Resources

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Revue de la littérature portant sur les personnes atteintes de troubles neurologiques ou du développement neurologique et sur le risque de présenter de graves complications liées à la grippe

Revue de la littérature portant sur les personnes atteintes de troubles neurologiques ou du développement neurologique et sur le risque de présenter de graves complications liées à la grippe

Un examen du comité consultatif : Comité consultatif national de l’immunisation (CCNI). Les résultats de la présente revue rapide de la littérature sont compatibles avec les données préliminaires selon lesquelles les enfants et adultes atteints de troubles neurologiques ou du développement neurologique constituent des groupes à risque d’hospitalisation et de complications liées à la grippe.

Corporate Authors: Comité consultatif national de l'immunisation

Publisher: Agence de la santé publique du Canada

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Stratégie de communication en cas de grippe pandémique : Stratégie de communication

Stratégie de communication en cas de grippe pandémique : Stratégie de communication

Cette stratégie repose sur plusieurs principes directeurs en matière de communications, à savoir privilégier en toute circonstance la santé des Canadiens, fournir de l'information de qualité rapidement, communiquer de façon coordonnée au niveau de l’ensemble des ordres de gouvernement, protéger la confidentialité et, enfin, surveiller la perception du risque de la population et s’y adapter. L'annexe décrit une approche de communication sur les risques, propose des déclencheurs d’intervention pour des pandémies ayant des répercussions variables et inclut un protocole de communication qui sera mis en œuvre à travers le pays, dans l’éventualité d'une pandémie.

Authors: Henry B

Corporate Authors: Groupe de travail sur le document Préparation du Canada en cas de grippe pandémique

Journal Title: CCDR

Journal Volume: 44-5

Publisher: Agence de la santé publique du Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Strengthening routine immunization through measles-rubella elimination

Strengthening routine immunization through measles-rubella elimination

The 2016 mid-term review of the Global Measles-Rubella Strategic Plan 2012–20 for achieving measles-rubella elimination concluded that the full potential of strategies and activities to strengthen routine immunization (RI) service delivery had not been met. In December 2017, researchers contacted the World Health Organization (WHO) and partner agency immunization staff in all six WHO Regions who identified 23 countries working on measles or rubella elimination that have implemented examples of recommended activities to improve RI, adapted to their needs.

Authors: Biellik RJ and Orenstein WA

Journal Issue: 37

Journal Title: Vaccine

Journal Volume: 36

Publisher: Elsevier

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: PDFTdap immunization during pregnancy: Pocket guide for immunizers

Tdap immunization during pregnancy: Pocket guide for immunizers

The National Advisory Committee on Immunization (NACI) recommends immunization with Tdap vaccine for all pregnant women, during each pregnancy, irrespective of previousTdap immunization history and interval between pregnancies.

Corporate Authors: Immunize Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link The vaccine hesitancy scale: Psychometric properties and validation

The vaccine hesitancy scale: Psychometric properties and validation

The SAGE Working Group on Vaccine Hesitancy developed a vaccine hesitancy measure, the Vaccine Hesitancy Scale (VHS). This scale has the potential to aid in the advancement of research and immunization policy but has not yet been psychometrically evaluated.

Authors: Shapiro GK et al.

Journal Issue: 5

Journal Title: Vaccine

Journal Volume: 36

Publisher: Elsevier

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Under-reporting of pertussis in Ontario: A Canadian Immunization Research Network (CIRN) study using capture-recapture

Under-reporting of pertussis in Ontario: A Canadian Immunization Research Network (CIRN) study using capture-recapture

Understanding the epidemiology of pertussis requires timely, reliable, and accurate surveillance data, but under-diagnosis and under-reporting of pertussis cases are longstanding challenges, compromising the ability to accurately estimate the burden of disease. Researchers aimed to estimate the true number of pertussis cases in Ontario separately in infants and those aged one year and over, and evaluate the completeness of each data source through a three-source capture-recapture data analysis.

Authors: Crowcroft N et al.

Journal Issue: 02 May 2018

Journal Title: PLOS One

Publisher: Public Library of Science

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Update on invasive meningococcal vaccination for Canadian children and youth

Update on invasive meningococcal vaccination for Canadian children and youth

Invasive meningococcal disease (IMD) is serious, often resulting in fulminant sepsis or meningitis. IMD in Canada is primarily attributable to serogroups B and C. There are routine programs for serogroup C vaccine at 12 months of age, with some jurisdictions routinely providing additional earlier doses. Adolescents routinely receive a booster dose of serogroup C vaccine or of a quadrivalent (serogroups A, C, W and Y) vaccine. Serogroup B vaccines are not recommended for routine use pending further data on the efficacy and duration of protection from the available vaccine. However, children at increased risk for IMD should start immunization for serogroups B and C as soon as possible, assuming that they are at least 2 months of age.

Authors: Robinson JL

Journal Issue: 1

Journal Title: Paediatrics & Child Health

Journal Volume: 23

Publisher: Oxford Academic

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Update on Maternal Immunization: Universal Tdap for Pregnant Women in Canada

Update on Maternal Immunization: Universal Tdap for Pregnant Women in Canada

Recorded video of SOGC webinar with Dr. Vanessa Poliquin.

Corporate Authors: Society of Obstetricians and Gynaecologists of Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Updated Recommendations on the Use of Herpes Zoster Vaccines

Updated Recommendations on the Use of Herpes Zoster Vaccines

Based on evidence reviewed and summarized in this advisory committee statement, the National Advisory Committee on Immunization makes recommendations on the use of previously recommended LZV and newly authorized RZV vaccine in populations and individuals.

Corporate Authors: National Advisory Committee on Immunization

Publisher: Public Health Agency of Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015

Reporting of adverse events following immunization (AEFI) is a key component for functional vaccine safety monitoring system. The aim of this study is to document trends in the AEFI reporting ratio globally and across the six World Health Organization (WHO) regions.

Authors: Lei J et al.

Journal Issue: 12

Journal Title: Vaccine

Journal Volume: 36

Publisher: Elsevier